BFM
VRTX icon

Boothbay Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Boothbay Fund Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$589K Buy
+1,320
New +$616K 0.01% 1255
2025
Q4 		– Sell
-611
Closed -$239K – 2407
2025
Q3 		$239K Buy
611
+81
+15% +$33.9K ﹤0.01% 1568
2025
Q2 		$236K Sell
530
-146
-22% -$67.3K ﹤0.01% 1190
2025
Q1 		$328K Buy
+676
New +$315K 0.01% 1034
2022
Q3 		– Sell
-5,323
Closed -$1.5M – 2630
2022
Q2 		$1.5M Buy
5,323
+2,175
+69% +$582K 0.04% 664
2022
Q1 		$822K Sell
3,148
-10,273
-77% -$2.44M 0.02% 1023
2021
Q4 		$2.95M Buy
13,421
+635
+5% +$123K 0.07% 351
2021
Q3 		$2.32M Sell
12,786
-1,371
-10% -$268K 0.06% 394
2021
Q2 		$2.85M Buy
14,157
+4,711
+50% +$985K 0.09% 264
2021
Q1 		$2.03M Buy
9,446
+3,213
+52% +$706K 0.08% 316
2020
Q4 		$1.47M Buy
+6,233
New +$1.43M 0.05% 358
2018
Q3 		– Sell
-1,282
Closed -$218K – 952
2018
Q2 		$218K Sell
1,282
-871
-40% -$135K 0.02% 596
2018
Q1 		$351K Buy
2,153
+413
+24% +$67.5K 0.04% 416
2017
Q4 		$261K Sell
1,740
-1,072
-38% -$159K 0.04% 482
2017
Q3 		$428K Buy
+2,812
New +$423K 0.07% 297
2017
Q2 		– Sell
-5,059
Closed -$553K – 856
2017
Q1 		$553K Buy
+5,059
New +$445K 0.1% 232

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boothbay Fund Management's VRTX Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 1,320 shares worth $589K. The stake represents 0.01% of the portfolio and ranks #1255 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in VRTX as recently as Q3 2025.

Boothbay Fund Management first reported a position in VRTX in Q1 2017 and has held it in 16 quarters since. The position peaked at $2.95M in Q4 2021. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Boothbay Fund Management held 1,320 shares of Vertex Pharmaceuticals worth $589K as of Q1 2026.
  • Vertex Pharmaceuticals was a new Boothbay Fund Management position in Q1 2026.
  • Vertex Pharmaceuticals made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1255 holding.
  • Boothbay Fund Management first reported a position in Vertex Pharmaceuticals in Q1 2017 and has held it in 16 quarters since.
  • Boothbay Fund Management's Vertex Pharmaceuticals position peaked at $2.95M in Q4 2021.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.